Quarterly report pursuant to Section 13 or 15(d)

COMMITMENTS AND CONTINGENCIES (Details Narrative)

v3.7.0.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
3 Months Ended
May 19, 2016
Mar. 31, 2017
Mar. 31, 2016
Rent expense   $ 12,314 $ 78,600
KriSan Biotech Co. Ltd [Member] | Research and Development Arrangement [Member]      
Long term purchase commitment amount $ 136,000